Journal article · 2022 · Open access

Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysis

Merlin Bresinsky, Jessica M. Strasser, Alexander Hubmann, Bernadette Vallaster, William M. McCue, Jessica L. Fuller, Gurpreet Singh, Kathryn M. Nelson, Matthew E. Cuellar, Barry C. Finzel, Karen H. Ashe, Michael A. Walters and 1 more

Archiv der Pharmazie, 355(9), e2200095 · Published 31 May 2022 · DOI 10.1002/ardp.202200095

Open PDFView at the publisherCite this paper

In brief

“Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysis” is a 2022 journal article by Merlin Bresinsky and 12 co-authors, published in Archiv der Pharmazie. OpenAlex counts 9 citations as of 22 November 2026. It is open access under a CC BY licence: the full text is free to read at Archiv der Pharmazie.

Citations
9
Most cited in
2026 (3)
Field-weighted impact
0.39
References
46
Authors
13

Abstract

Since the discovery of the caspase-2 (Casp2)-mediated ∆tau314 cleavage product and its associated impact on tauopathies such as Alzheimer's disease, the design of selective Casp2 inhibitors has become a focus in medicinal chemistry research. In the search for new lead structures with respect to Casp2 selectivity and drug-likeness, we have taken an approach by looking more closely at the specific sites of Casp2-mediated proteolysis. Using seven selected protein cleavage sequences, we synthesized a peptide series of 53 novel molecules and studied them using in vitro pharmacology, molecular modeling, and crystallography. Regarding Casp2 selectivity, AcITV(Dab)D-CHO (23) and AcITV(Dap)D-CHO (26) demonstrated the best selectivity (1-6-fold), although these trends were only moderate. However, some analogous tetrapeptides, most notably AcDKVD-CHO (45), showed significantly increased Casp3 selectivities (>100-fold). Tetra- and tripeptides display decreased or no Casp2 affinity, supporting the assumption that a motif of five amino acids is required for efficient Casp2 inhibition. Overall, the results provide a reasonable basis for the development of both selective Casp2 and Casp3 inhibitors.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Bresinsky, M., Strasser, J. M., Hubmann, A., Vallaster, B., McCue, W. M., Fuller, J. L., Singh, G., Nelson, K. M., Cuellar, M. E., Finzel, B. C., Ashe, K. H., Walters, M. A., & Pockes, S. (2022). Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysis. Archiv der Pharmazie, 355(9), e2200095. https://doi.org/10.1002/ardp.202200095

MLA 9

Bresinsky, Merlin, et al. “Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysis.” Archiv der Pharmazie, vol. 355, no. 9, 2022, p. e2200095. https://doi.org/10.1002/ardp.202200095.

Chicago

Bresinsky, Merlin, Jessica M. Strasser, Alexander Hubmann, Bernadette Vallaster, William M. McCue, Jessica L. Fuller, Gurpreet Singh, et al. 2022. “Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysis.” Archiv der Pharmazie 355 (9): e2200095. https://doi.org/10.1002/ardp.202200095.

Harvard

Bresinsky, M. et al. (2022) ‘Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysis’, Archiv der Pharmazie, 355(9), p. e2200095. doi:10.1002/ardp.202200095.

IEEE

M. Bresinsky et al., “Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysis,” Archiv der Pharmazie, vol. 355, no. 9, p. e2200095, 2022, doi: 10.1002/ardp.202200095.

BibTeX

@article{bresinsky2022characterization,
  title     = {{Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysis}},
  author    = {Bresinsky, Merlin and Strasser, Jessica M. and Hubmann, Alexander and Vallaster, Bernadette and McCue, William M. and Fuller, Jessica L. and Singh, Gurpreet and Nelson, Kathryn M. and Cuellar, Matthew E. and Finzel, Barry C. and Ashe, Karen H. and Walters, Michael A. and Pockes, Steffen},
  journal   = {Archiv der Pharmazie},
  year      = {2022},
  volume    = {355},
  number    = {9},
  pages     = {e2200095},
  doi       = {10.1002/ardp.202200095},
  url       = {https://doi.org/10.1002/ardp.202200095}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202211
202311
202422
202522
202633

Its field-weighted citation impact is 0.39: it has been cited 0.39 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation

  • tau cleavage
  • tauopathy
  • Alzheimer's disease
  • peptide inhibitors
  • cleavage specificity
  • drug-likeness

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Bresinsky, M., Strasser, J. M., Hubmann, A., Vallaster, B., McCue, W. M., Fuller, J. L., Singh, G., Nelson, K. M., Cuellar, M. E., Finzel, B. C., Ashe, K. H., Walters, M. A., & Pockes, S. (2022). Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysis. Archiv der Pharmazie, 355(9), e2200095. https://doi.org/10.1002/ardp.202200095

How many times has this paper been cited?

9 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Archiv der Pharmazie: sign in and open the PDF from this page.

Who wrote this paper?

Merlin Bresinsky, Jessica M. Strasser, Alexander Hubmann, Bernadette Vallaster, William M. McCue, Jessica L. Fuller, Gurpreet Singh, Kathryn M. Nelson, Matthew E. Cuellar, Barry C. Finzel, Karen H. Ashe, Michael A. Walters and 1 more.

What is the DOI of this paper?

10.1002/ardp.202200095, permanently at https://doi.org/10.1002/ardp.202200095. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.